跳至主要内容
临床试验/EUCTR2014-002170-36-SE
EUCTR2014-002170-36-SE
进行中(未招募)
不适用

Treatment of Cervical Spinal Cord Injury with Imatinib – a safety and feasibility study

Karolinska University Hospital0 个研究点2014年12月15日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Cervical Spinal Cord Injury
发起方
Karolinska University Hospital
状态
进行中(未招募)
最后更新
11年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2014年12月15日
结束日期
待定
最后更新
11年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

发起方
Karolinska University Hospital

入排标准

入选标准

  • 1\.Men and women aged 18\-80 years
  • 2\.Clinical signs of cervical spinal cord injury due to trauma
  • 3\.In otherwise good health condition as determined by past medical history, physical examination, laboratory tests and vital signs
  • 4\.Patient that is conscious and oriented x 4 (regarding date/time, localisation, situation and personal details), with higher level of consciousness, i.e. Glasgow Coma Scale \> 14, and is assessed to be competent to give informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 9
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 1

排除标准

  • 1\.Diabetes (type I and II)
  • 2\.Ongoing cancer treatment
  • 3\.Known allergy to study drug Imatinib or its excipients
  • 4\.On current therapy with drugs which may interfere with Imatinib, e.g. paracetamol, ketokonazol, itrakonazol, erythromycin and claritomycin Dexametason, phenytoin, karbamazepin, rifampizin, phenobarbital, fosphenytoin, primidon, Hypericum performatum (Johannesört).
  • 5\.Female subjects lactating or with positive pregnancy test
  • 6\.Known liver or kidney disease
  • 7\.Any relevant surgical or medical condition which in the opinion of the investigator may interfere with the conduct of the study or the scientific results. This includes hemorrhagic conditions.

结局指标

主要结局

未指定

相似试验